QuantAbundanciaAbundance, Quantified.

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

21,290 signal articles · 510 in last 24h · 104,317 total before filter · latest 1h ago
510last 24h
2499last 7d
479● bullish (7d)
254● bearish (7d)
198publishers
AllMacro206Earnings1501M&A142Regulatory15Product7Analyst29
Sentiment:bullishneutralbearishshow all (incl. clickbait)
Bloomberg2d agobearish
Alibaba Drops Another China AI Model With Breakthrough Performance

(Bloomberg) -- Alibaba Group Holding Ltd. released its latest flagship AI model, with performance claims putting it alongside global leaders like Anthropic’s Fable.Most Read from BloombergTrump Says US to Hold Off Iran Attack If Deal AgreedSaudi Prince Concerned Over Trump’s Iran Strike Plan: AxiosSingapore's Gated Island for the Rich Is Marred by Decayed HomesIndia’s Family Offices Embrace Profit-Sharing to Attract Top TalentCrushed by Kospi Rout, Angry Koreans Rip Lee and Vow Not to BuyThe new

SpaceX Investors Want a Pink Rocket and a Starship Named 'Shipy McShipface' Ahead of First Earnings: Top Questions for Elon Musk's Team Revealed
Benzinga2d agoneutral
SpaceX Investors Want a Pink Rocket and a Starship Named 'Shipy McShipface' Ahead of First Earnings: Top Questions for Elon Musk's Team Revealed

Ahead of Space Exploration Technologies Corp.‘s (NASDAQ:SPCX) first public earnings report on Tuesday after the bell, investors submitted questions ranging from whether Starship could be painted pink or named “Shipy McShipface” to AI infrastructure, Starlink expansion and missions to Mars. SpaceX Opens the Floor to Investors SpaceX invited investors to submit questions through a new Grok-powered platform, allowing shareholders to vote on the topics they want management to answer. Among the light

Bloomberg3d agobearish
Korean Stocks Drop as Chipmakers Reverse Friday’s Record Gains

(Bloomberg) -- South Korean stocks slipped, as heavyweight chipmakers faced selloffs after Friday’s record gains while investors cut back leverage-backed trades. Most Read from BloombergTrump Says US to Hold Off Iran Attack If Deal AgreedSaudi Prince Concerned Over Trump’s Iran Strike Plan: AxiosSingapore's Gated Island for the Rich Is Marred by Decayed HomesIndia’s Family Offices Embrace Profit-Sharing to Attract Top TalentCrushed by Kospi Rout, Angry Koreans Rip Lee and Vow Not to BuyThe Kospi

Starbucks CEO says your local store may not survive
TheStreet3d agoneutral
Starbucks CEO says your local store may not survive

Your neighborhood Starbucks (SBUX) might look bulletproof, especially if it survived ballooning rents, changing commutes, and years of customers ordering the same morning drink. However, Starbucks is no longer looking at treating every existing café as untouchable. The chain is becoming much ...

Costco's changes fix members' biggest problems
TheStreet3d agoneutral
Costco's changes fix members' biggest problems

Membership sales and retention drive Costco's business and the chain has succeeded in creating a very loyal membership base. "Who we found is the best at customer loyalty is Costco, which may not be surprising," UBS Analyst Michael Lasser told CNBC. Costco, he noted, excels at value and ...

Bloomberg3d agoneutral
AI and Chips Are Turning Malaysia Into Asia’s Growth Standout

(Bloomberg) -- Joel William is about to begin a feasibility study for a Chinese client weighing a chemical plant in Sarawak, Malaysia’s biggest state on the northern coast of Borneo.Most Read from BloombergTrump Says US to Hold Off Iran Attack If Deal AgreedSaudi Prince Concerned Over Trump’s Iran Strike Plan: AxiosSingapore's Gated Island for the Rich Is Marred by Decayed HomesIndia’s Family Offices Embrace Profit-Sharing to Attract Top TalentCrushed by Kospi Rout, Angry Koreans Rip Lee and Vow

Novo Nordisk shares in hot water after disappointing trial
TheStreet3d agoneutral
Novo Nordisk shares in hot water after disappointing trial

Investors who had hopes that Novo Nordisk (NVO) could succeed outside of weight-loss drugs were disappointed on Friday, July 31. The Danish drugmaker said its experimental heart drug Ziltivekimab failed the main goal of a large late-stage trial, and the stock fell fast. Novo has spent 2026 trying ...

Why Morgan Stanley won’t call Rivian a buy despite upgrade
TheStreet3d agobullish
Why Morgan Stanley won’t call Rivian a buy despite upgrade

Nine years ago, Tesla nearly drained its cash reserves trying to scale a new vehicle line, a stretch of chaos Elon Musk later called production hell. Rivian (RIVN) is now running its own version of that gauntlet with the R2, the affordable SUV meant to turn a niche automaker into a mass-market one. ...

Analyst sends strong signal on SpaceX stock before earnings
TheStreet3d agoneutral
Analyst sends strong signal on SpaceX stock before earnings

SpaceX (SPCX) is to report second quarter earnings on August 4, offering investors their first look at how it might justify its nosebleed valuation. Ahead of the report, shareholders are bracing for another Big Tech-style quarter, marred by heavy spending, uncertain cash flow, and a looming ...